News from MarketWatch Top Stories
What is your interest today?
Tariffs
Investors
Ceo
Stock
Shares
Earnings
Stocks
Eqs
China
Cet
Nasdaq
Investment
Markets
Wall Street
Tesla
Nvidia
Trade
Inflation
Revenue
Securities
Class Action
Stock Market
Economy
Bitcoin
Company
Us
Federal Reserve
Sales
Apple
Prices
Sp 500
Ipo
Pvr
Trade War
Crypto
Interest Rates
Amazon
Companies
Shareholders
Federal Securities Laws
German Securities Trading Act
Voting Rights
Guidance
Warren Buffett
Gop
Trading
Elon Musk
Securities Laws
Berkshire Hathaway
Investor
Healthcare
Digimarc Corporation
Antitrust
Attrition
Lly
Task Force
Global Business
Hong Kong Shares
Illinois
Ai Stocks
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Marketwatch Top Stories headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
MarketWatch Top Stories • May 12, 2025
Here’s how much extra weight is lost with Zepbound over Wegovy
A recent comparison of two popular weight-loss medications highlighted a measurable difference in effectiveness, potentially influencing market share and revenue for the companies...
Read Full Article →